{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:38:57Z","timestamp":1759333137737,"version":"3.41.2"},"reference-count":40,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946202163006","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T12:41:20Z","timestamp":1611924080000},"source":"Crossref","is-referenced-by-count":4,"title":["A real-life study on the impact of direct-acting antivirals in the treatment of chronic hepatitis C in liver transplant recipients at two university centers in Northeastern Brazil"],"prefix":"10.1590","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2503-1340","authenticated-orcid":false,"given":"Isabella Patr\u00edcia Lima","family":"Silva","sequence":"first","affiliation":[{"name":"Universidade Federal de Pernambuco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7996-5053","authenticated-orcid":false,"given":"Andrea D\u00f3ria","family":"Batista","sequence":"additional","affiliation":[{"name":"Universidade Federal de Pernambuco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3470-1564","authenticated-orcid":false,"given":"Edmundo Pessoa","family":"Lopes","sequence":"additional","affiliation":[{"name":"Universidade Federal de Pernambuco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7549-9825","authenticated-orcid":false,"given":"Norma Arteiro","family":"Filgueira","sequence":"additional","affiliation":[{"name":"Universidade Federal de Pernambuco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo Times de","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Universidade de Pernambuco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelma Carvalho","family":"Santos","sequence":"additional","affiliation":[{"name":"Universidade Federal de Pernambuco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tib\u00e9rio Batista de","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Instituto Professor Fernando Figueira de Medicina Integral,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa Ramos Lacerda de","family":"Melo","sequence":"additional","affiliation":[{"name":"Escola de Sa\u00fade de Pernambuco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha S\u00e1 de","family":"Lima","sequence":"additional","affiliation":[{"name":"Faculdade Maur\u00edcio de Nassau,  Brazil; Hospital Oswaldo Cruz,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2505-7516","authenticated-orcid":false,"given":"Kledoaldo","family":"Lima","sequence":"additional","affiliation":[{"name":"Universidade Federal de Pernambuco,  Brazil; European Virus Bioinformatics Center,  Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Lacerda","sequence":"additional","affiliation":[{"name":"Universidade de Pernambuco,  Brazil; Universidade de Pernambuco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9872-7571","authenticated-orcid":false,"given":"Heloisa Ramos","family":"Lacerda","sequence":"additional","affiliation":[{"name":"Universidade Federal de Pernambuco,  Brazil; Universidade Federal de Pernambuco,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2021]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s11096-017-0552-1","article-title":"Adverse effects of direct acting antiviral-based regimens in chronic hepatitis C patients: a Brazilian experience","volume":"39","author":"Medeiros T","year":"2017","journal-title":"Int J Clin Pharm"},{"year":"2017","series-title":"Guidelines on hepatitis B and C testing","key":"ref2"},{"issue":"Esp","key":"ref3","first-page":"1","article-title":"Hepatites virais 2020","year":"2020","journal-title":"Bol Epidemiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1590\/S1413-86702004000500003","article-title":"Demographic and anthropometrical analysis and genotype distribution of chronic hepatitis C patients treated in public and private reference centers in Brazil","volume":"8","author":"Focaccia R","year":"2004","journal-title":"Braz J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virusres.2012.06.023","article-title":"Distribution and molecular characterization of hepatitis C virus (HCV) genotypes in patients with chronic infection from Pernambuco State, Brazil","volume":"169","author":"Alvarado-Mora MV","year":"2012","journal-title":"Virus Res"},{"year":"2017","series-title":"Protocolo cl\u00ednico e diretrizes terap\u00eauticas para hepatite C e coinfec\u00e7\u00f5es","key":"ref6"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL recommendations on treatment of hepatitis C 2015","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2008.05.002","article-title":"Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin","volume":"49","author":"Berenguer M","year":"2008","journal-title":"J Hepatol"},{"key":"ref9","series-title":"Boceprevir and Telaprevir in the management of hepatitis C virus infected patients","first-page":"96","volume":"54","author":"Butt AA","year":"2012"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13027","article-title":"Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives","volume":"36","author":"Asselah T","year":"2016","journal-title":"Liver Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(14)61036-9","article-title":"Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study","volume":"384","author":"Lawitz E","year":"2014","journal-title":"Lancet"},{"year":"2015","series-title":"Protocolo cl\u00ednico e diretrizes terap\u00eauticas para hepatite C e coinfec\u00e7\u00f5es","key":"ref13"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","article-title":"New hepatitis C therapies: the toolbox, strategies, and challenges","volume":"146","author":"Pawlotsky JM","year":"2014","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bjid.2018.04.003","article-title":"Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil","volume":"22","author":"Ferreira VL","year":"2018","journal-title":"Braz J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bjid.2018.06.004","article-title":"Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the public health system in Brazil","volume":"22","author":"Holzmann I","year":"2018","journal-title":"Braz J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.clinre.2019.02.009","article-title":"Prevalence of baseline NS3 resistance-associated substitutions (RASs) on treatment with protease inhibitors in patients infected with HCV genotype 1","volume":"43","author":"Costa VD","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5604\/01.3001.0010.2717","article-title":"Treatment of chronic HCV infection with the new direct acting antivirals (DAA): first report of a real-world experience in Southern Brazil","volume":"16","author":"Cheinquer H","year":"2017","journal-title":"Ann Hepatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.transproceed.2018.02.001","article-title":"Daclatasvir and Sofosbuvir with or without Ribavirin in liver transplant recipients: a single-center real-world study","volume":"50","author":"Mucenic M","year":"2018","journal-title":"Transplant Proc"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.aohep.2018.09.004","article-title":"Sofosbuvir-based antiviral therapy in patients with recurrent HCV infection after liver transplant : a real-life experience","volume":"18","author":"Araujo A","year":"2019","journal-title":"Ann Hepatol"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20198519","article-title":"Recurrent hepatitis C treatment with direct-acting antivirals: a real-life study at a Brazilian liver transplant centre","volume":"52","author":"Zanaga LP","year":"2019","journal-title":"Braz J Med Biol Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jcv.2006.11.007","article-title":"Evaluation of the Abbott RealTime HCV assay for quantitative detection of hepatitis C virus RNA","volume":"38","author":"Michelin BD","year":"2007","journal-title":"J Clin Virol"},{"key":"ref23","series-title":"Trends in immunolabelled and related techniques","first-page":"340","volume-title":"An overview of the laboratory assay systems and reactives used in the diagnosis of Hepatitis C virus (HCV) infections","author":"Kesli R","year":"2012"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling RK","year":"2006","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C","volume":"20","year":"1994","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai C","year":"2003","journal-title":"Hepatology"},{"year":"2019","series-title":"Protocolo cl\u00ednico e diretrizes terap\u00eauticas para hepatite C e coinfec\u00e7\u00f5es","key":"ref27"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2016.05.039","article-title":"Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence: the ANRS CUPILT study","volume":"65","author":"Coilly A","year":"2016","journal-title":"J Hepatol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/hep.28446","article-title":"Daclatasvir with Sofosbuvir and Ribavirin for Hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence","volume":"63","author":"Poordad F","year":"2016","journal-title":"Hepatology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/lt.24126","article-title":"Sofosbuvir and Simeprevir for treatment of hepatitis C virus infection in liver transplant recipients","volume":"21","author":"Gutierrez JA","year":"2015","journal-title":"Liver Transpl"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hep.27770","article-title":"Multicenter experience using Simeprevir and Sofosbuvir with or without Ribavirin to treat Hepatitis C genotype 1 after liver transplant","volume":"61","author":"Pungpapong S","year":"2015","journal-title":"Hepatology"},{"key":"ref32","article-title":"Direct-acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: systematic review and meta-analysis","volume":"21","author":"Liu J","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.aohep.2019.08.001","article-title":"Direct antiviral therapy for the treatment of hepatitis C: a real-world study from Brazil","volume":"18","author":"Lobato CM","year":"2019","journal-title":"Ann Hepatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cgh.2017.04.038","article-title":"Magnitude and kinetics of decrease in liver stiffness after anti-viral therapy in patients with chronic Hepatitis C: a systematic review and meta-analysis Siddharth","volume":"16","author":"Singh S","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13334","article-title":"Longitudinal assessment of hepatic fibrosis in responders to direct-acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methods","volume":"32","author":"Omar H","year":"2018","journal-title":"Clin Transplant"},{"key":"ref36","article-title":"Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents","volume":"19","author":"Hsu WF","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/TP.0000000000001467","article-title":"Sofosbuvir\/Ledipasvir without Ribavirin achieved high sustained virologic response for hepatitis C recurrence after liver transplantation: two-center experience","volume":"101","author":"Elfeki MA","year":"2017","journal-title":"Transplantion"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.transproceed.2017.09.057","article-title":"Therapy with direct-acting antiviral agents for hepatitis C in liver transplant recipients","volume":"50","author":"Nogueras L\u00f3pez F","year":"2018","journal-title":"Transplant Proc"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s12325-019-01012-6","article-title":"Assessing patient preferences for treatment decisions for new direct-acting antiviral (DAA) therapies for chronic hepatitis C virus infections","volume":"36","author":"Welzel TM","year":"2019","journal-title":"Adv Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.2147\/DDDT.S139837","article-title":"Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort","volume":"11","author":"Bernuth S","year":"2017","journal-title":"Drug Des Devel Ther"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v63\/1678-9946-rimtsp-63-S1678-9946202163006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T07:02:31Z","timestamp":1613113351000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652021000100204&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":40,"alternative-id":["S0036-46652021000100204"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202163006","relation":{},"ISSN":["1678-9946"],"issn-type":[{"type":"electronic","value":"1678-9946"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"e6"}}